Advertisement
Screener

DAVITA INC. (DVA) Overview

DAVITA INC. (DVA) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 4.02; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 2.87; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 2.04; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 2.58; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$98.68$119.12$143.81$173.61$209.58$253.012025-11-062026-11-06$62.15$82.30$108.97$144.30$191.07$253.012021-11-082026-11-06$41.25$59.29$85.21$122.47$176.03$253.012016-11-072026-11-06$20.11$33.37$55.38$91.89$152.47$253.012006-11-062026-11-06$0.81$2.55$8.05$25.39$80.16$253.011995-10-312026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$191.37
Previous close
$175.19
Change
$16.18
Change (%)
9.24%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

DVA
+54.20%
S&P 500
(m)

1 year

DVA
+34.15%
S&P 500
(m)

3 years

DVA
+85.33%
S&P 500
(m)

5 years

DVA
+44.56%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 4.02

1.922.493.063.634.2031 Mar 2025: estimate (m); actual 2.0031 Mar 2025(m)30 Jun 2025: estimate (m); actual 2.5830 Jun 2025(m)30 Sept 2025: estimate (m); actual 2.0430 Sept 2025(m)31 Mar 2026: estimate (m); actual 2.8731 Mar 2026(m)30 Jun 2026: estimate (m); actual 4.0230 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)4.02(m)(m)
1 Jan 202631 Mar 2026(m)2.87(m)(m)
1 Jul 202530 Sept 2025(m)2.04(m)(m)
1 Apr 202530 Jun 2025(m)2.58(m)(m)
1 Jan 202531 Mar 2025(m)2.00(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 9.84

5.777.058.349.6310.9131 Dec 2021: estimate (m); actual 8.9031 Dec 2021(m)31 Dec 2022: estimate (m); actual 5.8531 Dec 2022(m)31 Dec 2023: estimate (m); actual 7.4231 Dec 2023(m)31 Dec 2024: estimate (m); actual 10.7331 Dec 2024(m)31 Dec 2025: estimate (m); actual 9.8431 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)9.84(m)(m)
1 Jan 202431 Dec 2024(m)10.73(m)(m)
1 Jan 202331 Dec 2023(m)7.42(m)(m)
1 Jan 202231 Dec 2022(m)5.85(m)(m)
1 Jan 202131 Dec 2021(m)8.90(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 3.55B ■ Earnings 0.27B — Profit margin 7.47%

-0.43B3.4%1.06B7.8%2.56B12.2%4.05B16.6%30 Sept 2025: revenue 3.42B; earnings 0.15B; profit margin 4.40%30 Sept 202531 Dec 2025: revenue 3.62B*; earnings 0.57B*; profit margin 15.64%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 3.42B; earnings 0.20B; profit margin 5.78%31 Mar 202630 Jun 2026: revenue 3.55B; earnings 0.27B; profit margin 7.47%30 Jun 2026

31 Dec 2025 ■ Revenue 13.64B ■ Earnings 1.08B — Profit margin 7.91%

-1.64B5.7%4.00B7.4%9.64B9.1%15.28B10.8%31 Dec 2022: revenue 11.61B; earnings 0.78B; profit margin 6.73%31 Dec 202231 Dec 2023: revenue 12.14B; earnings 0.96B; profit margin 7.88%31 Dec 202331 Dec 2024: revenue 12.82B; earnings 1.25B; profit margin 9.76%31 Dec 202431 Dec 2025: revenue 13.64B; earnings 1.08B; profit margin 7.91%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$191.37(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$191.37High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning DVA

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$1.18B
Profit margin
8.42%
Return on assets · 12 month
6.70%
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
727.25K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-4.64%*
Total return · month
-3.04%*
Total return · quarter
-20.26%*
Total return · half year
13.44%*
Total return · year to date
54.20%*
Total return · 1 year
34.15%*
Total return · 3 years
85.33%*
Total return · 5 years
44.56%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$14.01B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

DAVITA INC. Overview

View more →

(m)

(m)

SEC CIK
927066
Industry (SIC)
8090 Services-Misc Health & Allied Services, NEC
Country of operation
United States
Business address
2000 16TH STREET, DENVER, Colorado, 80202, United States
Fiscal year end
1231
Phone
310-536-2668

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sotera Health Co (SHC)United States$5.271B30.96
Progyny, Inc. (PGNY)United States$1.994B28.37
agilon health, inc. (AGL)United States$1.272B-7.76
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43